GlassScriptPhysician profile
Keith Aaron Schiff
NPI 1154548691
$9,532.46
in general payments reported to CMS, 2019-2025
23 companies · $1,791 in 2025
The $1,791 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,683 · 2020: $736 · 2021: $37.35 · 2022: $1,842 · 2023: $868 · 2024: $1,576 · 2025: $1,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,234.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,297.43 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Medtronic USA, INC. | $2,890.43 | 2019-2020 | |
| Saluda Medical Americas, INC. | $306.46 | 2025 | Evoke |
| Electronic Waveform Lab, INC. | $279.43 | 2019-2020 | |
| Nalu Medical, INC. | $234.71 | 2022-2025 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.09 | 2020-2022 | |
| Nevro Corp. | $53.38 | 2019 | |
| Arbor Pharmaceuticals, INC. | $49.60 | 2019-2021 | |
| Boston Scientific Corporation | $41.49 | 2019-2020 | |
| Inari Medical, INC. | $40.92 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $37.62 | 2023-2024 | Proclaim |
| Virtus Pharmaceuticals LLC | $20.83 | 2020 | |
| Ermi LLC | $19.73 | 2019 | |
| Neurelis, INC. | $19.46 | 2024 | Valtoco |
| Argenx US, INC. | $19.42 | 2025 | Vyvgart Hytrulo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $18.17 | 2025 | Monovisc, Orthovisc |
| Impel Pharmaceuticals INC. | $17.87 | 2022 | |
| Scilex Pharmaceuticals INC. | $17.17 | 2019 | |
| Nuvasive, INC. | $16.27 | 2019 | |
| Fidia Pharma USA INC. | $16.25 | 2024 | Hym/Hyn |
| Daiichi Sankyo INC. | $16.03 | 2019 | |
| Ibsa Pharma INC. | $12.37 | 2021 | |
| Biodelivery Sciences International, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Schiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.